Cas:64415-15-2 1-hydroxy-4-sulfamoylnaphthalene-2-carboxylic acid manufacturer & supplier

We serve Chemical Name:1-hydroxy-4-sulfamoylnaphthalene-2-carboxylic acid CAS:64415-15-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-hydroxy-4-sulfamoylnaphthalene-2-carboxylic acid

Chemical Name:1-hydroxy-4-sulfamoylnaphthalene-2-carboxylic acid
CAS.NO:64415-15-2
Synonyms:4-Aminosulfonyl-1-hydroxy-2-naphthoic acid;1-hydroxy-4-sulfamoyl-2-naphthoic acid;2-Naphthalenecarboxylic acid,4-(aminosulfonyl)-1-hydroxy
Molecular Formula:C11H9NO5S
Molecular Weight:267.25800
HS Code:

Physical and Chemical Properties:
Melting point:225ºC
Boiling point:555ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:126.07000
Exact Mass:267.02000
LogP:2.67210

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Aminosulfonyl-1-hydroxy-2-naphthoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Naphthalenecarboxylic acid,4-(aminosulfonyl)-1-hydroxy physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Aminosulfonyl-1-hydroxy-2-naphthoic acid Use and application,4-Aminosulfonyl-1-hydroxy-2-naphthoic acid technical grade,usp/ep/jp grade.


Related News: “The most important thing to be considered while determining a CDMO competency is their technical knowledge along with adequate expertise to accomplish the drug development till commercial scaling. 3,6-Dibromo-2-furan-2-yl-8-methyl-chromen-4-one manufacturers The Global Talent Visa, along with the High Potential Individual and Scale-up visa routes in the Innovation Strategy, provide fast-track visa routes for high skills individuals and their teams, attracting top research talent to the UK. 4,6-diamino-2-(3-aminopropyl)-5-(phenylazo)pyrimidine suppliers The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. TEBP-p-Cl vendor & factory.